Delivery Order SPE2DR25D3016-SPE2DR26FG2RT
- Not listed
- The Defense Logistics Agency awarded a $1,008.00 delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60 ml) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price contract, with no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,408.32 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities. This contract, executed on December 11, 2025, with completion scheduled for December 12, 2025, utilizes firm fixed-price pricing and represents a non-set-aside competitive award. The delivery location is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60 ml quantities, with a contract ceiling value of $1,564.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Oseltamivir 6 mg/ml suspension in 60ml quantities, with a contract ceiling value of $1,450.25. This firm fixed-price delivery order, which has no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60ml) with a contract value of $3,047.20 on December 3, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by December 4, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency has awarded a delivery order valued at $4,540.32 to AmerisourceBergen Drug Corp for Oseltamivir 6 mg/ml suspension (60 ml units). This is a firm fixed price delivery order with an ultimate completion date of December 24, 2025, and was awarded on December 23, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded through an open...
- The Defense Logistics Agency awarded a $2,280.08 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract, valued at $1,099.36, represents a firm fixed price delivery order with an ultimate completion date of December 16, 2025. This award was not set aside for small business or other socioeconomic categories and was competitively awarded. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 on December 16, 2025. This firm fixed price delivery order, valued at $2,776.22, is scheduled for completion by December 17, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was made competitively. This delivery order is issued under AmerisourceBergen...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2RTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,025.68 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Oseltamivir 6 mg/ml Suspension in 60ml quantities. This competitive award, which carries a firm fixed price structure with no set-aside designation, is scheduled for completion by December 30, 2025, with fulfillment to occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's DLA prime indefinite delivery contract functions as a comprehensive global pharmaceutical support vehicle, enabling delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, and specialized medical commodities. This specific delivery order for antiviral medication reflects the company's ongoing role in supplying essential pharmaceuticals to defense and healthcare agency customers through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/28/25 |